Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician’s perspective

Michele Fornaro, Lubna Kardash, Stefano Novello, Andrea Fusco, Annalisa Anastasia, Domenico De Berardis, Giampaolo Perna, Mauro Giovanni Carta

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)221-228
Number of pages8
JournalExpert Opinion on Drug Discovery
Volume13
Issue number3
DOIs
Publication statusPublished - 22 Jan 2018

Keywords

  • Bipolar disorder (BD)
  • drug design
  • novel therapeutic targets
  • PLACEBO-CONTROLLED TRIAL
  • RANDOMIZED CONTROLLED-TRIALS
  • GLYCOGEN-SYNTHASE KINASE-3
  • ADJUNCTIVE THERAPY
  • DOUBLE-BLIND
  • INTERNATIONAL SOCIETY
  • ANTIDEPRESSANT DRUGS
  • ALZHEIMERS-DISEASE
  • ANXIETY DISORDERS
  • CIRCADIAN GENES

Cite this

Fornaro, M., Kardash, L., Novello, S., Fusco, A., Anastasia, A., De Berardis, D., Perna, G., & Carta, M. G. (2018). Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician’s perspective. Expert Opinion on Drug Discovery, 13(3), 221-228. https://doi.org/10.1080/17460441.2018.1428554